GlassScriptPhysician profile
Dina R Edrich
NPI 1891074746
$10,307.49
in general payments reported to CMS, 2019-2025
58 companies · $1,284 in 2025
The $1,284 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,166 · 2020: $15.95 · 2021: $1,379 · 2022: $2,128 · 2023: $2,540 · 2024: $1,795 · 2025: $1,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,619.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $978.01 | 2019-2025 | Airsupra, Farxiga, Andexxa |
| Novo Nordisk INC | $975.56 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $828.00 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $679.42 | 2019-2025 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $665.94 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $525.65 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $450.58 | 2021-2024 | Acthar |
| Abbvie INC. | $419.25 | 2022-2024 | Qulipta, Ubrelvy, Viberzi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $398.86 | 2021-2025 | Jardiance, Synjardy |
| Janssen Pharmaceuticals, INC | $367.21 | 2019-2024 | Xarelto |
| Abbott Laboratories | $360.12 | 2022-2025 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $338.29 | 2022-2024 | Quviviq |
| Mylan Specialty L.P. | $244.07 | 2021-2022 | |
| Astellas Pharma US INC | $180.56 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $176.49 | 2023-2025 | Gemtesa |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $176.02 | 2021-2022 | |
| Exact Sciences Corporation | $175.06 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $170.96 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $169.81 | 2021-2023 | |
| Horizon Therapeutics Plc | $167.18 | 2022 | |
| Angiodynamics, INC. | $159.61 | 2023 | Nanoknife |
| Genzyme Corporation | $149.34 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.60 | 2022-2025 | Xifaxan, Trulance |
| Akcea Therapeutics, INC. | $118.73 | 2019 | |
| Amarin Pharma, INC. | $111.15 | 2019-2022 | |
| United Therapeutics Corporation | $82.47 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $73.05 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $64.38 | 2021 | |
| Radius Health, INC. | $64.08 | 2019 | |
| Novartis Pharmaceuticals Corporation | $61.95 | 2021-2023 | |
| Esperion Therapeutics, INC. | $61.32 | 2022-2025 | Nexletol |
| Boston Scientific Corporation | $59.90 | 2024-2025 | Watchman Flx |
| Jazz Pharmaceuticals INC. | $55.30 | 2021 | |
| Ani Pharmaceuticals, INC. | $55.02 | 2022-2025 | Purified Cortrophin Gel |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $51.02 | 2025 | Caplyta |
| Vbi Vaccine (Delaware) INC. | $49.73 | 2023 | Prehevbrio |
| Merck Sharp & Dohme LLC | $49.45 | 2019-2024 | Capvaxive, Gardasil 9, Gardasil |
| Sunovion Pharmaceuticals INC. | $45.26 | 2022 | |
| Inogen, INC. | $45.07 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Phadia US INC. | $43.25 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $34.30 | 2022-2023 | Seglentis, Livalo |
| Insightec,INC | $32.97 | 2025 | Exablate |
| Dexcom, INC. | $23.54 | 2025 | Dexcom G6 Transmitter |
| Nestle Healthcare Nutrition INC. | $20.39 | 2023 | |
| Electromed, INC. | $19.60 | 2021 | |
| Seqirus USA INC | $18.83 | 2021 | |
| Ardelyx, INC. | $18.80 | 2024 | Ibsrela |
| Hologic Sales and Service, LLC | $17.90 | 2022 | |
| Verona Pharma, INC. | $17.49 | 2025 | Ohtuvayre |
| Hikma Pharmaceuticals USA | $17.43 | 2022 | |
| Pulmonx Corporation | $15.53 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Ibsa Pharma INC. | $15.50 | 2022 | |
| Biogen, INC. | $15.13 | 2021 | |
| Currax Pharmaceuticals LLC | $14.35 | 2021 | |
| Baxter Healthcare | $13.94 | 2022 | |
| Almatica Pharma LLC | $13.85 | 2021 | |
| Paratek Pharmaceuticals, INC. | $12.95 | 2021 | |
| Nabriva Therapeutics, Plc | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dina Edrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.